80 related articles for article (PubMed ID: 146766)
1. Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells.
Berlinger NT; Hilal EY; Oettgen HF; Good RA
Laryngoscope; 1978 Mar; 88(3):470-83. PubMed ID: 146766
[TBL] [Abstract][Full Text] [Related]
2. Abnormal dinitrochlorobenzene skin sensitization: a prognostic sign of survival in head and neck squamous cell carcinoma.
Maisel RH; Ogura JH
Laryngoscope; 1973 Dec; 83(12):2012-9. PubMed ID: 4772104
[No Abstract] [Full Text] [Related]
3. [The value of CEA in post-therapeutic monitoring of head and neck carcinoma].
Fiorella R; Di Nicola V; Giannubilo C; Facondo M
Acta Otorhinolaryngol Ital; 1988; 8(2):133-6. PubMed ID: 3188902
[No Abstract] [Full Text] [Related]
4. A search for common tumor specific antigen and serum blocking factor in head and neck epidermoid carcinomas.
Kennedy JT
Laryngoscope; 1975 May; 85(5):806-22. PubMed ID: 49834
[TBL] [Abstract][Full Text] [Related]
5. [Cellular immune defect caused by postoperative irradiation in patients with squamous epithelial carcinomas of the upper aerodigestive tract].
Maier H; Daniel V; Heimlich F; Frank C; Opelz G
HNO; 1995 Jun; 43(6):364-70. PubMed ID: 7642397
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen class I expression on squamous cell carcinoma cells regulates natural killer cell activity.
Lutz CT; Kurago ZB
Cancer Res; 1999 Nov; 59(22):5793-9. PubMed ID: 10582701
[TBL] [Abstract][Full Text] [Related]
7. [Immune functions in cancers of the upper respiratory and digestive tracts].
Follézou JY; Bayssas M; Provost MA; Fridman WH; Dumont J; Point D; Brugère J
Nouv Presse Med; 1978 Oct; 7(37):3368. PubMed ID: 733515
[No Abstract] [Full Text] [Related]
8. [Immunity indices of patients with locally disseminated malignant neoplasms of the head and neck].
Bulbuk GA
Vopr Onkol; 1982; 28(4):57-9. PubMed ID: 7090271
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulating effects of surgical intervention in tumors of the head and neck.
Dietz A; Heimlich F; Daniel V; Polarz H; Weidauer H; Maier H
Otolaryngol Head Neck Surg; 2000 Jul; 123(1 Pt 1):132-9. PubMed ID: 10889496
[TBL] [Abstract][Full Text] [Related]
10. Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients.
Wara WM; Ammann AJ; Wara DW
Cancer Treat Rep; 1978 Nov; 62(11):1775-8. PubMed ID: 728896
[TBL] [Abstract][Full Text] [Related]
11. Decreased sensitivity of T lymphocytes to normal adherent suppressor cells in patients with head and neck cancer.
Pierri I; Cordone G; Rogna S; Pende D; Garaventa G; Barabino A; Indiveri F
Cancer Detect Prev; 1984; 7(2):73-8. PubMed ID: 6231991
[TBL] [Abstract][Full Text] [Related]
12. Transference of cell mediated immunity in patients with head and neck cancer.
Vetto RM; Burger DR
Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
[TBL] [Abstract][Full Text] [Related]
13. Detection and localization of tumor-associated immune components of head and neck squamous cell carcinomas.
Popović D; Gill L; Sisson G; Applebaum E; Anderson B
Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976; 82(2):119-30. PubMed ID: 59450
[No Abstract] [Full Text] [Related]
14. Levamisole versus placebo as an adjunct to primary therapy of laryngopharyngeal epidermoid carcinoma. Evaluation of the immune status.
Mussche RA; Plum J; de Smedt M; Kluyskens P
Acta Otorhinolaryngol Belg; 1977; 31(6):566-77. PubMed ID: 339662
[TBL] [Abstract][Full Text] [Related]
15. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)].
Niksić M; Balogh M
Laryngol Rhinol Otol (Stuttg); 1976 Nov; 55(11):882-7. PubMed ID: 136570
[TBL] [Abstract][Full Text] [Related]
16. Failure of cell-mediated effector mechanisms in lung cancer.
Feo Figarella E; Morillo F; Blanca I; Bianco NE
J Natl Cancer Inst; 1984 Jul; 73(1):1-6. PubMed ID: 6330420
[TBL] [Abstract][Full Text] [Related]
17. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients.
Spina CA; Dorey F; Vescera C; Brosman S; Fahey JL
Cancer Res; 1981 Nov; 41(11 Pt 1):4324-30. PubMed ID: 6458353
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine production and lymphocyte subpopulations in patients with head and neck squamous carcinoma.
Wolf GT; Lovett EJ; Peterson KA; Beauchamp ML; Baker SR
Arch Otolaryngol; 1984 Nov; 110(11):731-5. PubMed ID: 6237633
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cell-mediated immunity in oral cancer patients.
Rao RS; Fakih AR; Nair CN; Gangal SG; Naik SL
Indian J Cancer; 1984 Nov-1985 Jan; 21(5-6):141-5. PubMed ID: 6336234
[No Abstract] [Full Text] [Related]
20. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
Uchida A; Klein E
J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
